We also observed no difference in the distribution of HEV-3 variants between hepatitis patients from Scotland with symptoms of hepatitis compared with those without such symptoms or to those with ALT levels < 2000 or ≥ 2000 U l− 1 (Table 1). This evidence concerns the gene GPT and Hepatitis.